Advertisement
Screener

CLEARARC CAPITAL INC Historic Quarter Change: Foreign Stocks, Added

CLEARARC CAPITAL INC historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, CLEARARC CAPITAL INC opened 6 positions, added to 10, reduced 14 and sold out of 9.

  • Q3 2015: Stock NVS; Country of operation —; Class ADR; Shares before 4,509.
  • Q3 2015: Stock SNY; Country of operation —; Class ADR; Shares before 14,117.
  • Q2 2015: Stock BP; Country of operation —; Class ADR; Shares before 19,220.
  • Q1 2015: Stock NVS; Country of operation —; Class ADR; Shares before 2,181.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1167553), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-11); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-17); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-03-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2015NVS
NOVARTIS AG-SPONSORED ADR
ADR4,5095,624+1,115$443,000$517,000+$74,0002015-11-13
Q3 2015SNY
SANOFI-ADR
ADR14,11715,571+1,454$699,000$739,000+$40,0002015-11-13
Q2 2015BP
BP PLC-SPONS ADR
ADR19,22019,905+685$752,000$795,000+$43,0002015-08-14
Q1 2015NVS
NOVARTIS AG-SPONSORED ADR
ADR2,18112,203+10,022$202,000$1,203,000+$1,001,0002015-05-14
Q4 2014TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR17,66819,874+2,206$950,000$1,143,000+$193,0002015-02-13
Q3 2014TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR15,61117,668+2,057$818,000$950,000+$132,0002014-11-17
Q2 2014TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR15,06715,611+544$796,000$818,000+$22,0002014-08-14
Q1 2014RHHBY
ROCHE HOLDINGS LTD-SPONS ADR
ADR27,66651,022+23,356$1,938,000$1,913,000-$25,0002014-05-15
Q4 2013TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR13,50116,352+2,851$510,000$655,000+$145,0002014-02-14
Q3 2013TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR8,62913,501+4,872$338,000$510,000+$172,0002013-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet